BOF (BOF) Stock Price & Analysis
BOF (BOF) fell 1.29% to USD 3.81 as of September 8, 2026 at 10:57 UTC, according to Nexqual real-time market data.
BOF last closed at USD 3.81; the session ranged USD 3.81–3.99 on volume of 10,438 shares. Market capitalization is —, with a 52-week range of USD 1.93–5.25 (NCM). Source: Nexqual, September 8, 2026 at 10:57 UTC.
Key Statistics (as of September 8, 2026 at 10:57 UTC)
| Price | USD 3.81 |
|---|---|
| Change | ▼ 1.29% (down) |
| Previous Close | USD 3.81 |
| Open | USD 3.81 |
| Day Range | USD 3.81 – 3.99 |
| 52-Week Range | USD 1.93 – 5.25 |
| Volume | 10,438 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (BOF)
Nexqual's technical model rates BOF "STRONG SELL" based on 0 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 10:57 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 42.2 (neutral) |
| vs SMA50 | Below (USD 4.14) |
| MACD | -0.06 (negative) |
From BOF's Latest SEC 10-K Filing (filed 2026-03-31)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ATPC | Agape ATP Corporation | USD 2.39 | ▲ 3.46% |
| CCTG | CCSC Technology International H | USD 0.62 | ▼ 1.74% |
| LRHC | La Rosa Holdings Corp. | USD 2.9 | ▲ 0% |
| TVGN | Tevogen Inc. | USD 7.34 | ▲ 2.37% |
| BDRX | Biodexa Pharmaceuticals plc | USD 0.85 | ▲ 8.03% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 10:57 UTC. This page is informational and not investment advice.